The Indian benchmark equity indices erased the intraday gains to close lower for the second consecutive day on Thursday. The NSE Nifty 50 ended 48.1 points or 0.19% lower at 25,405.30, while the BSE ...

Regeneron Pharmaceuticals has received accelerated FDA approval for Lynozyfic, a new bispecific antibody treatment for adults with relapsed or refractory multiple myeloma who have undergone at least ...

In a large cohort study, patients with ASDs have significantly better all-cause and cancer-specific survival after antineoplastic therapy compared with those without an autoimmune skin disease.

The Korea Research Institute of Standards and Science has successfully developed a nanomaterial capable of simultaneously ...